価格表

在庫・価格 : 2024年05月07日 17時33分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Vaspin, Human, ELISA Kit(96tests)
データシート
AG-45A-0017YEK-KI01 KOMアディポジェン ライフ サイエンシーズ
Adipogen Life Sciences
1 kit ¥149,000
(未発注)
追加

在庫・価格 : 2024年05月07日 17時33分 現在

Vaspin, Human, ELISA Kit(96tests)

  • 商品コード:AG-45A-0017YEK-KI01
  • メーカー:KOM
  • 包装:1kit
  • 価格: ¥149,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008 Mar;17(3):327-33
Wada J
2008/01/01
PubMed
2 Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008 Mar;17(3):327-33
Wada J
2008/01/01
PubMed
3 Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008 Mar;17(3):327-33
Wada J
2008/01/01
PubMed
4 Tan BK et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008 Jun;57(6):1501-7
Tan BK et al
2008/01/01
PubMed
5 Aust G et al. Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis 2009 May;204(1):262-6
Aust G et al
2009/01/01
PubMed
6 Gulcelik NE et al. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009 Jan;160(1):65-70
Gulcelik NE et al
2009/01/01
PubMed
7 Ib叩単ez L et al. Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months. Clin Endocrinol (Oxf)
Ib叩単ez L et al
2009/01/01
PubMed
8 Escobar-Morreale HF et al. Serum visceral adipose tissue-derived serine protease inhibitor concentrations in human obesity and polycystic ovary syndrome. Diabetes Care 2009 Jan;32(1):e6
Escobar-Morreale HF et al
2009/01/01
PubMed
9 Handisurya A et al. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg 2010 Feb;20(2):198-203
Handisurya A et al
2010/01/01
PubMed
10 Cho JK et al. Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. Eur. J. Appl. Physiol. 2010 Jan;108(2):347-53
Cho JK et al
2010/01/01
PubMed
11 Senolt L et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 2010 Jul;69(7):1410-1
Senolt L et al
2010/01/01
PubMed
12 von Loeffelholz C et al. Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur J Endocrinol 2010 Mar;162(3):507-13
von Loeffelholz C et al
2010/01/01
PubMed
13 Kukla M et al. Chemerin, vaspin and insulin resistance in chronic hepatitis C. J Viral Hepat 2010 Sep;17(9):661-7
Kukla M et al
2010/01/01
PubMed
14 Lee MK et al. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta 2010 Mar;411(5-6):381-5
Lee MK et al
2010/01/01
PubMed
15 Stepan H et al. Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism 2010 Jul;59(7):1054-6
Stepan H et al
2010/01/01
PubMed
16 Chang HM et al. Association between serum vaspin concentrations and visceral adipose tissue in Korean subjects. Metabolism 2010 Sep;59(9):1276-81
Chang HM et al
2010/01/01
PubMed
17 Kukla M et al. Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010;45(2):235-42
Kukla M et al
2010/01/01
PubMed
18 Jeong E et al. Circadian rhythm of serum vaspin in healthy male volunteers: relation to meals. J Clin Endocrinol Metab 2010 Apr;95(4):1869-75
Jeong E et al
2010/01/01
PubMed
19 Chang HM et al. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity (Silver Spring) 2010 Nov;18(11):2105-10
Chang HM et al
2010/01/01
PubMed
20 Derosa G et al. Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients. Metabolism 2011 Mar;60(3):421-9
Derosa G et al
2011/01/01
PubMed
21 Briana DD et al. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies. Metabolism 2011 Apr;60(4):486-90
Briana DD et al
2011/01/01
PubMed
22 Derosa G et al. Comparison of orlistat treatment and placebo in obese type 2 diabetic patients. Expert Opin Pharmacother 2010 08;11(12):1971-82
Derosa G et al
2010/01/01
PubMed
23 El-Mesallamy HO et al. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 2011 Jan;60(1):63-70
El-Mesallamy HO et al
2011/01/01
PubMed
24 Cakal E et al. Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome. Gynecol Endocrinol 2011 Jul;27(7):491-5
Cakal E et al
2011/01/01
PubMed
25 K旦rner A et al. Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int J Obes (Lond) 2011 Apr;35(4):578-86
K旦rner A et al
2011/01/01
PubMed
26 Derosa G et al. Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients. Fundam Clin Pharmacol 2011 Oct;25(5):642-51
Derosa G et al
2011/01/01
PubMed
27 Derosa G et al. Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients. Hypertens. Res. 2011 Jan;34(1):145-51
Derosa G et al
2011/01/01
PubMed
28 Martos-Moreno GÁ et al. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism. Int J Obes (Lond) 2011 Oct;35(10):1355-62
Martos-Moreno GÁ et al
2011/01/01
PubMed
29 Fioravanti A et al. Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease. Rheumatol Int 2012 May;32(5):1481-2
Fioravanti A et al
2012/01/01
PubMed
30 Kim SM et al. Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations. Metabolism 2011 Sep;60(9):1294-9
Kim SM et al
2011/01/01
PubMed
31 Auguet T et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med. Genet. 2011 Apr;12:60
Auguet T et al
2011/01/01
PubMed
32 Šenolt L et al. Adipokine profile is modulated in subcutaneous adipose tissue by TNFα inhibitors in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2011 Nov;70(11):2054-6
Šenolt L et al
2011/01/01
PubMed
33 Cinar N et al. Serum vaspin levels in hypothyroid patients. Eur J Endocrinol 2011 Oct;165(4):563-9
Cinar N et al
2011/01/01
PubMed
34 Li HL et al. Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris. Clin Chem Lab Med 2011 Sep;49(9):1547-54
Li HL et al
2011/01/01
PubMed
35 Assadi M et al. Correlation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissue. PLoS ONE 2011;6(9):e24240
Assadi M et al
2011/01/01
PubMed
36 Terra X et al. Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines. Clin. Endocrinol. (Oxf) 2012 Nov;77(5):691-8
Terra X et al
2012/01/01
PubMed
37 Bl端her M et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012 Feb;35(2):342-9
Bl端her M et al
2012/01/01
PubMed
38 Kukla M et al. Association between hepatic angiogenesis and serum adipokine profile in non-obese chronic hepatitis C patients. Pol J Pathol 2011 Dec;62(4):218-28
Kukla M et al
2011/01/01
PubMed
39 Golpaie A et al. Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects. Eur Cytokine Netw 2011 Dec;22(4):181-6
Golpaie A et al
2011/01/01
PubMed
40 Saalbach A et al. Vaspin--a link of obesity and psoriasis? Exp Dermatol 2012 Apr;21(4):309-12
Saalbach A et al
2012/01/01
PubMed
41 Klaasen R et al. Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis. Ann Rheum Dis 2012 Sep;71(9):1510-6
Klaasen R et al
2012/01/01
PubMed
42 Schindler K et al. The impact of type 2 diabetes on circulating adipokines in patients with metabolic syndrome. Obes Facts 2012;5(2):270-6
Schindler K et al
2012/01/01
PubMed
43 Breitfeld J et al. Genetic variation in the vaspin gene affects circulating serum vaspin concentrations. Int J Obes (Lond) 2013 Jun;37(6):861-6
Breitfeld J et al
2013/01/01
PubMed
44 Li HL et al. Association of vaspin gene polymorphisms with coronary artery disease in Chinese population and function study. Clin Chim Acta 2013 Jan;415:233-8
Li HL et al
2013/01/01
PubMed
45 Goktas Z et al. Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects. Mediators Inflamm. 2013;2013:861496
Goktas Z et al
2013/01/01
PubMed
46 Esteghamati A et al. Association of vaspin with metabolic syndrome: the pivotal role of insulin resistance. Diabetes Metab J 2014 Apr;38(2):143-9
Esteghamati A et al
2014/01/01
PubMed
47 Flehmig G et al. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS ONE 2014;9(6):e99785
Flehmig G et al
2014/01/01
PubMed
48 Bao JP et al. Expression of vaspin in the joint and the levels in the serum and synovial fluid of patients with osteoarthritis. Int J Clin Exp Med 2014;7(10):3447-53
Bao JP et al
2014/01/01
PubMed
49 Guvenc Y et al. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome. J Int Med Res 2016 Aug;44(4):796-805
Guvenc Y et al
2016/01/01
PubMed
50 Then C et al. Association of serum uromodulin with adipokines in dependence of type 2 diabetes. Cytokine 2022 02;150:155786
Then C et al
2022/01/01
PubMed
51 Seeger J et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008 Jan;93(1):247-51
Seeger J et al
2008/01/01
PubMed
52 Youn BS et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008 Feb;57(2):372-7
Youn BS et al
2008/01/01
PubMed
53 Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008 Mar;17(3):327-33
Wada J
2008/01/01
PubMed
54 Tan BK et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008 Jun;57(6):1501-7
Tan BK et al
2008/01/01
PubMed
55 Aust G et al. Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis 2009 May;204(1):262-6
Aust G et al
2009/01/01
PubMed
56 Gulcelik NE et al. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009 Jan;160(1):65-70
Gulcelik NE et al
2009/01/01
PubMed
57 Ib叩単ez L et al. Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months. Clin Endocrinol (Oxf)
Ib叩単ez L et al
2009/01/01
PubMed
58 Escobar-Morreale HF et al. Serum visceral adipose tissue-derived serine protease inhibitor concentrations in human obesity and polycystic ovary syndrome. Diabetes Care 2009 Jan;32(1):e6
Escobar-Morreale HF et al
2009/01/01
PubMed
59 Handisurya A et al. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg 2010 Feb;20(2):198-203
Handisurya A et al
2010/01/01
PubMed
60 Cho JK et al. Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. Eur. J. Appl. Physiol. 2010 Jan;108(2):347-53
Cho JK et al
2010/01/01
PubMed
61 Senolt L et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 2010 Jul;69(7):1410-1
Senolt L et al
2010/01/01
PubMed
62 von Loeffelholz C et al. Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur J Endocrinol 2010 Mar;162(3):507-13
von Loeffelholz C et al
2010/01/01
PubMed
63 Kukla M et al. Chemerin, vaspin and insulin resistance in chronic hepatitis C. J Viral Hepat 2010 Sep;17(9):661-7
Kukla M et al
2010/01/01
PubMed
64 Lee MK et al. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta 2010 Mar;411(5-6):381-5
Lee MK et al
2010/01/01
PubMed
65 Stepan H et al. Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism 2010 Jul;59(7):1054-6
Stepan H et al
2010/01/01
PubMed
66 Chang HM et al. Association between serum vaspin concentrations and visceral adipose tissue in Korean subjects. Metabolism 2010 Sep;59(9):1276-81
Chang HM et al
2010/01/01
PubMed
67 Kukla M et al. Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010;45(2):235-42
Kukla M et al
2010/01/01
PubMed
68 Jeong E et al. Circadian rhythm of serum vaspin in healthy male volunteers: relation to meals. J Clin Endocrinol Metab 2010 Apr;95(4):1869-75
Jeong E et al
2010/01/01
PubMed
69 Chang HM et al. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity (Silver Spring) 2010 Nov;18(11):2105-10
Chang HM et al
2010/01/01
PubMed
70 Derosa G et al. Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients. Metabolism 2011 Mar;60(3):421-9
Derosa G et al
2011/01/01
PubMed
71 Briana DD et al. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies. Metabolism 2011 Apr;60(4):486-90
Briana DD et al
2011/01/01
PubMed
72 Derosa G et al. Comparison of orlistat treatment and placebo in obese type 2 diabetic patients. Expert Opin Pharmacother 2010 08;11(12):1971-82
Derosa G et al
2010/01/01
PubMed
73 El-Mesallamy HO et al. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 2011 Jan;60(1):63-70
El-Mesallamy HO et al
2011/01/01
PubMed
74 Cakal E et al. Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome. Gynecol Endocrinol 2011 Jul;27(7):491-5
Cakal E et al
2011/01/01
PubMed
75 K旦rner A et al. Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int J Obes (Lond) 2011 Apr;35(4):578-86
K旦rner A et al
2011/01/01
PubMed
76 Derosa G et al. Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients. Fundam Clin Pharmacol 2011 Oct;25(5):642-51
Derosa G et al
2011/01/01
PubMed
77 Derosa G et al. Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients. Hypertens. Res. 2011 Jan;34(1):145-51
Derosa G et al
2011/01/01
PubMed
78 Martos-Moreno GÁ et al. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism. Int J Obes (Lond) 2011 Oct;35(10):1355-62
Martos-Moreno GÁ et al
2011/01/01
PubMed
79 Fioravanti A et al. Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease. Rheumatol Int 2012 May;32(5):1481-2
Fioravanti A et al
2012/01/01
PubMed
80 Kim SM et al. Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations. Metabolism 2011 Sep;60(9):1294-9
Kim SM et al
2011/01/01
PubMed
81 Auguet T et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med. Genet. 2011 Apr;12:60
Auguet T et al
2011/01/01
PubMed
82 Šenolt L et al. Adipokine profile is modulated in subcutaneous adipose tissue by TNFα inhibitors in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2011 Nov;70(11):2054-6
Šenolt L et al
2011/01/01
PubMed
83 Cinar N et al. Serum vaspin levels in hypothyroid patients. Eur J Endocrinol 2011 Oct;165(4):563-9
Cinar N et al
2011/01/01
PubMed
84 Li HL et al. Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris. Clin Chem Lab Med 2011 Sep;49(9):1547-54
Li HL et al
2011/01/01
PubMed
85 Assadi M et al. Correlation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissue. PLoS ONE 2011;6(9):e24240
Assadi M et al
2011/01/01
PubMed
86 Terra X et al. Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines. Clin. Endocrinol. (Oxf) 2012 Nov;77(5):691-8
Terra X et al
2012/01/01
PubMed
87 Bl端her M et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012 Feb;35(2):342-9
Bl端her M et al
2012/01/01
PubMed
88 Kukla M et al. Association between hepatic angiogenesis and serum adipokine profile in non-obese chronic hepatitis C patients. Pol J Pathol 2011 Dec;62(4):218-28
Kukla M et al
2011/01/01
PubMed
89 Golpaie A et al. Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects. Eur Cytokine Netw 2011 Dec;22(4):181-6
Golpaie A et al
2011/01/01
PubMed
90 Saalbach A et al. Vaspin--a link of obesity and psoriasis? Exp Dermatol 2012 Apr;21(4):309-12
Saalbach A et al
2012/01/01
PubMed
91 Klaasen R et al. Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis. Ann Rheum Dis 2012 Sep;71(9):1510-6
Klaasen R et al
2012/01/01
PubMed
92 Schindler K et al. The impact of type 2 diabetes on circulating adipokines in patients with metabolic syndrome. Obes Facts 2012;5(2):270-6
Schindler K et al
2012/01/01
PubMed
93 Breitfeld J et al. Genetic variation in the vaspin gene affects circulating serum vaspin concentrations. Int J Obes (Lond) 2013 Jun;37(6):861-6
Breitfeld J et al
2013/01/01
PubMed
94 Li HL et al. Association of vaspin gene polymorphisms with coronary artery disease in Chinese population and function study. Clin Chim Acta 2013 Jan;415:233-8
Li HL et al
2013/01/01
PubMed
95 Goktas Z et al. Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects. Mediators Inflamm. 2013;2013:861496
Goktas Z et al
2013/01/01
PubMed
96 Esteghamati A et al. Association of vaspin with metabolic syndrome: the pivotal role of insulin resistance. Diabetes Metab J 2014 Apr;38(2):143-9
Esteghamati A et al
2014/01/01
PubMed
97 Flehmig G et al. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS ONE 2014;9(6):e99785
Flehmig G et al
2014/01/01
PubMed
98 Bao JP et al. Expression of vaspin in the joint and the levels in the serum and synovial fluid of patients with osteoarthritis. Int J Clin Exp Med 2014;7(10):3447-53
Bao JP et al
2014/01/01
PubMed
99 Guvenc Y et al. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome. J Int Med Res 2016 Aug;44(4):796-805
Guvenc Y et al
2016/01/01
PubMed
100 Then C et al. Association of serum uromodulin with adipokines in dependence of type 2 diabetes. Cytokine 2022 02;150:155786
Then C et al
2022/01/01
PubMed
101 Seeger J et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008 Jan;93(1):247-51
Seeger J et al
2008/01/01
PubMed
102 Youn BS et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008 Feb;57(2):372-7
Youn BS et al
2008/01/01
PubMed
  • No.: 1
  • 文献情報:
    Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008 Mar;17(3):327-33
    Wada J
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008 Mar;17(3):327-33
    Wada J
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008 Mar;17(3):327-33
    Wada J
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Tan BK et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008 Jun;57(6):1501-7
    Tan BK et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Aust G et al. Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis 2009 May;204(1):262-6
    Aust G et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Gulcelik NE et al. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009 Jan;160(1):65-70
    Gulcelik NE et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Ib叩単ez L et al. Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months. Clin Endocrinol (Oxf)
    Ib叩単ez L et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Escobar-Morreale HF et al. Serum visceral adipose tissue-derived serine protease inhibitor concentrations in human obesity and polycystic ovary syndrome. Diabetes Care 2009 Jan;32(1):e6
    Escobar-Morreale HF et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Handisurya A et al. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg 2010 Feb;20(2):198-203
    Handisurya A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Cho JK et al. Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. Eur. J. Appl. Physiol. 2010 Jan;108(2):347-53
    Cho JK et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Senolt L et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 2010 Jul;69(7):1410-1
    Senolt L et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    von Loeffelholz C et al. Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur J Endocrinol 2010 Mar;162(3):507-13
    von Loeffelholz C et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Kukla M et al. Chemerin, vaspin and insulin resistance in chronic hepatitis C. J Viral Hepat 2010 Sep;17(9):661-7
    Kukla M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Lee MK et al. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta 2010 Mar;411(5-6):381-5
    Lee MK et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Stepan H et al. Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism 2010 Jul;59(7):1054-6
    Stepan H et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Chang HM et al. Association between serum vaspin concentrations and visceral adipose tissue in Korean subjects. Metabolism 2010 Sep;59(9):1276-81
    Chang HM et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Kukla M et al. Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010;45(2):235-42
    Kukla M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Jeong E et al. Circadian rhythm of serum vaspin in healthy male volunteers: relation to meals. J Clin Endocrinol Metab 2010 Apr;95(4):1869-75
    Jeong E et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Chang HM et al. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity (Silver Spring) 2010 Nov;18(11):2105-10
    Chang HM et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Derosa G et al. Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients. Metabolism 2011 Mar;60(3):421-9
    Derosa G et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Briana DD et al. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies. Metabolism 2011 Apr;60(4):486-90
    Briana DD et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Derosa G et al. Comparison of orlistat treatment and placebo in obese type 2 diabetic patients. Expert Opin Pharmacother 2010 08;11(12):1971-82
    Derosa G et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    El-Mesallamy HO et al. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 2011 Jan;60(1):63-70
    El-Mesallamy HO et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Cakal E et al. Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome. Gynecol Endocrinol 2011 Jul;27(7):491-5
    Cakal E et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    K旦rner A et al. Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int J Obes (Lond) 2011 Apr;35(4):578-86
    K旦rner A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Derosa G et al. Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients. Fundam Clin Pharmacol 2011 Oct;25(5):642-51
    Derosa G et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Derosa G et al. Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients. Hypertens. Res. 2011 Jan;34(1):145-51
    Derosa G et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Martos-Moreno GÁ et al. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism. Int J Obes (Lond) 2011 Oct;35(10):1355-62
    Martos-Moreno GÁ et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Fioravanti A et al. Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease. Rheumatol Int 2012 May;32(5):1481-2
    Fioravanti A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Kim SM et al. Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations. Metabolism 2011 Sep;60(9):1294-9
    Kim SM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Auguet T et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med. Genet. 2011 Apr;12:60
    Auguet T et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Šenolt L et al. Adipokine profile is modulated in subcutaneous adipose tissue by TNFα inhibitors in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2011 Nov;70(11):2054-6
    Šenolt L et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Cinar N et al. Serum vaspin levels in hypothyroid patients. Eur J Endocrinol 2011 Oct;165(4):563-9
    Cinar N et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Li HL et al. Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris. Clin Chem Lab Med 2011 Sep;49(9):1547-54
    Li HL et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Assadi M et al. Correlation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissue. PLoS ONE 2011;6(9):e24240
    Assadi M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Terra X et al. Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines. Clin. Endocrinol. (Oxf) 2012 Nov;77(5):691-8
    Terra X et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Bl端her M et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012 Feb;35(2):342-9
    Bl端her M et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Kukla M et al. Association between hepatic angiogenesis and serum adipokine profile in non-obese chronic hepatitis C patients. Pol J Pathol 2011 Dec;62(4):218-28
    Kukla M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Golpaie A et al. Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects. Eur Cytokine Netw 2011 Dec;22(4):181-6
    Golpaie A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Saalbach A et al. Vaspin--a link of obesity and psoriasis? Exp Dermatol 2012 Apr;21(4):309-12
    Saalbach A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Klaasen R et al. Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis. Ann Rheum Dis 2012 Sep;71(9):1510-6
    Klaasen R et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Schindler K et al. The impact of type 2 diabetes on circulating adipokines in patients with metabolic syndrome. Obes Facts 2012;5(2):270-6
    Schindler K et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Breitfeld J et al. Genetic variation in the vaspin gene affects circulating serum vaspin concentrations. Int J Obes (Lond) 2013 Jun;37(6):861-6
    Breitfeld J et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Li HL et al. Association of vaspin gene polymorphisms with coronary artery disease in Chinese population and function study. Clin Chim Acta 2013 Jan;415:233-8
    Li HL et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Goktas Z et al. Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects. Mediators Inflamm. 2013;2013:861496
    Goktas Z et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Esteghamati A et al. Association of vaspin with metabolic syndrome: the pivotal role of insulin resistance. Diabetes Metab J 2014 Apr;38(2):143-9
    Esteghamati A et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Flehmig G et al. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS ONE 2014;9(6):e99785
    Flehmig G et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Bao JP et al. Expression of vaspin in the joint and the levels in the serum and synovial fluid of patients with osteoarthritis. Int J Clin Exp Med 2014;7(10):3447-53
    Bao JP et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Guvenc Y et al. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome. J Int Med Res 2016 Aug;44(4):796-805
    Guvenc Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Then C et al. Association of serum uromodulin with adipokines in dependence of type 2 diabetes. Cytokine 2022 02;150:155786
    Then C et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Seeger J et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008 Jan;93(1):247-51
    Seeger J et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Youn BS et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008 Feb;57(2):372-7
    Youn BS et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008 Mar;17(3):327-33
    Wada J
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Tan BK et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008 Jun;57(6):1501-7
    Tan BK et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Aust G et al. Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis 2009 May;204(1):262-6
    Aust G et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Gulcelik NE et al. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009 Jan;160(1):65-70
    Gulcelik NE et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Ib叩単ez L et al. Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months. Clin Endocrinol (Oxf)
    Ib叩単ez L et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Escobar-Morreale HF et al. Serum visceral adipose tissue-derived serine protease inhibitor concentrations in human obesity and polycystic ovary syndrome. Diabetes Care 2009 Jan;32(1):e6
    Escobar-Morreale HF et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Handisurya A et al. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg 2010 Feb;20(2):198-203
    Handisurya A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Cho JK et al. Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. Eur. J. Appl. Physiol. 2010 Jan;108(2):347-53
    Cho JK et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Senolt L et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 2010 Jul;69(7):1410-1
    Senolt L et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    von Loeffelholz C et al. Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur J Endocrinol 2010 Mar;162(3):507-13
    von Loeffelholz C et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Kukla M et al. Chemerin, vaspin and insulin resistance in chronic hepatitis C. J Viral Hepat 2010 Sep;17(9):661-7
    Kukla M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Lee MK et al. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta 2010 Mar;411(5-6):381-5
    Lee MK et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Stepan H et al. Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism 2010 Jul;59(7):1054-6
    Stepan H et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Chang HM et al. Association between serum vaspin concentrations and visceral adipose tissue in Korean subjects. Metabolism 2010 Sep;59(9):1276-81
    Chang HM et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Kukla M et al. Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010;45(2):235-42
    Kukla M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Jeong E et al. Circadian rhythm of serum vaspin in healthy male volunteers: relation to meals. J Clin Endocrinol Metab 2010 Apr;95(4):1869-75
    Jeong E et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Chang HM et al. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity (Silver Spring) 2010 Nov;18(11):2105-10
    Chang HM et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Derosa G et al. Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients. Metabolism 2011 Mar;60(3):421-9
    Derosa G et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Briana DD et al. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies. Metabolism 2011 Apr;60(4):486-90
    Briana DD et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Derosa G et al. Comparison of orlistat treatment and placebo in obese type 2 diabetic patients. Expert Opin Pharmacother 2010 08;11(12):1971-82
    Derosa G et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    El-Mesallamy HO et al. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 2011 Jan;60(1):63-70
    El-Mesallamy HO et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Cakal E et al. Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome. Gynecol Endocrinol 2011 Jul;27(7):491-5
    Cakal E et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    K旦rner A et al. Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int J Obes (Lond) 2011 Apr;35(4):578-86
    K旦rner A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Derosa G et al. Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients. Fundam Clin Pharmacol 2011 Oct;25(5):642-51
    Derosa G et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Derosa G et al. Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients. Hypertens. Res. 2011 Jan;34(1):145-51
    Derosa G et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Martos-Moreno GÁ et al. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism. Int J Obes (Lond) 2011 Oct;35(10):1355-62
    Martos-Moreno GÁ et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Fioravanti A et al. Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease. Rheumatol Int 2012 May;32(5):1481-2
    Fioravanti A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Kim SM et al. Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations. Metabolism 2011 Sep;60(9):1294-9
    Kim SM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Auguet T et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med. Genet. 2011 Apr;12:60
    Auguet T et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Šenolt L et al. Adipokine profile is modulated in subcutaneous adipose tissue by TNFα inhibitors in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2011 Nov;70(11):2054-6
    Šenolt L et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Cinar N et al. Serum vaspin levels in hypothyroid patients. Eur J Endocrinol 2011 Oct;165(4):563-9
    Cinar N et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Li HL et al. Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris. Clin Chem Lab Med 2011 Sep;49(9):1547-54
    Li HL et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Assadi M et al. Correlation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissue. PLoS ONE 2011;6(9):e24240
    Assadi M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Terra X et al. Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines. Clin. Endocrinol. (Oxf) 2012 Nov;77(5):691-8
    Terra X et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Bl端her M et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012 Feb;35(2):342-9
    Bl端her M et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Kukla M et al. Association between hepatic angiogenesis and serum adipokine profile in non-obese chronic hepatitis C patients. Pol J Pathol 2011 Dec;62(4):218-28
    Kukla M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Golpaie A et al. Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects. Eur Cytokine Netw 2011 Dec;22(4):181-6
    Golpaie A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Saalbach A et al. Vaspin--a link of obesity and psoriasis? Exp Dermatol 2012 Apr;21(4):309-12
    Saalbach A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    Klaasen R et al. Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis. Ann Rheum Dis 2012 Sep;71(9):1510-6
    Klaasen R et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Schindler K et al. The impact of type 2 diabetes on circulating adipokines in patients with metabolic syndrome. Obes Facts 2012;5(2):270-6
    Schindler K et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Breitfeld J et al. Genetic variation in the vaspin gene affects circulating serum vaspin concentrations. Int J Obes (Lond) 2013 Jun;37(6):861-6
    Breitfeld J et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 94
  • 文献情報:
    Li HL et al. Association of vaspin gene polymorphisms with coronary artery disease in Chinese population and function study. Clin Chim Acta 2013 Jan;415:233-8
    Li HL et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 95
  • 文献情報:
    Goktas Z et al. Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects. Mediators Inflamm. 2013;2013:861496
    Goktas Z et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 96
  • 文献情報:
    Esteghamati A et al. Association of vaspin with metabolic syndrome: the pivotal role of insulin resistance. Diabetes Metab J 2014 Apr;38(2):143-9
    Esteghamati A et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 97
  • 文献情報:
    Flehmig G et al. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS ONE 2014;9(6):e99785
    Flehmig G et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 98
  • 文献情報:
    Bao JP et al. Expression of vaspin in the joint and the levels in the serum and synovial fluid of patients with osteoarthritis. Int J Clin Exp Med 2014;7(10):3447-53
    Bao JP et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 99
  • 文献情報:
    Guvenc Y et al. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome. J Int Med Res 2016 Aug;44(4):796-805
    Guvenc Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 100
  • 文献情報:
    Then C et al. Association of serum uromodulin with adipokines in dependence of type 2 diabetes. Cytokine 2022 02;150:155786
    Then C et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 101
  • 文献情報:
    Seeger J et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008 Jan;93(1):247-51
    Seeger J et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 102
  • 文献情報:
    Youn BS et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008 Feb;57(2):372-7
    Youn BS et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed